MEMBERS
0
AUD$0.00 0 items

No products in the cart.

First patients receive minibeam radiation therapy

First patients receive minibeam radiation therapy

First patients receive minibeam radiation therapy

23 August 2024

Two cancer patients at Mayo Clinic in Minnesota USA have responded well to minibeam radiation therapy (MBRT). This is the first time the therapy has been performed on humans.

Patient one, whose armpit tumour initially measured 14x14x11cm, reported a reduction in pain and an increase in mobility in the days following treatment. After three weeks the tumour had shrunk by 63%.

Patient two, whose 7x6x3cm ear tumour caused hearing loss and shooting pain, reported improved hearing and reduced pain in the days following treatment. Thirty-four days later, the tumour had completely flattened (see image).

Four images labelled A,B,C and D. (A) The tumour of patient two on the day of MBRT. (B) Treatment photo showing the patient with the collimator holder attached, the 5 cm cone flush and in contact with the tungsten collimator. Tumour response 16 days (C) and 34 days (D) after MBRT.
Treatment response: (A) The tumour of patient two on the day of MBRT. (B) Treatment photo showing the patient with the collimator holder attached, the 5cm cone flush and in contact with the tungsten collimator. Tumour response 16 days (C) and 34 days (D) after MBRT. (Image credit: Int. J. Radiat. Oncol. Biol. Phys. 10.1016/j.ijrobp.2024.06.035)

MBRT is a new technique that targets cancers with alternating high-dose “peak” and low-dose “valley” radiation doses.

The Mayo Clinic team delivered radiation via a 12x12cm portable tungsten collimator, which was attached to the patient so that when the patient moved, the collimator moved with them. This set-up offers flexibility for patients with mobility issues, or those who find it difficult to stay still for extended periods.

MBRT in Australia is still a while away, with Mayo Clinic’s Radiation Oncology Medical Physicist, Michael Grams, saying the next step for researchers will be to determine the maximum tolerated dose rate. He says the team is also researching combinations of MBRT and systemic therapies like immunotherapy and chemotherapy.

The Mayo Clinic case studies were published in the Int. Journal of Radiation Oncology – Biology – Physics.

In March 2025, Mayo Clinic’s Director of Particle Therapy, Professor Anita Mahajan, will present the latest news from the Clinic’s proton beam therapy facility, at the ASMIRT/NZIMRT Conference in Adelaide. For more information, head to the conference website.

Member Benefit Spectrum.
Member Advantage program
Member Benefit CPD
Member Benefit professional insurances

Keep Informed

Join the ASMIRT community and stay up to date. Get the latest news from the Australian Society of Medical Imaging and Radiation Therapy.
We will send you regular updates via our eNews newsletter.
Subscription Form

ASMIRT

Australian Society of Medical
Imaging and Radiation Therapy
Suite 1040-1044 (Level 10),
1 Queens Road Melbourne
VIC 3004 Australia
Australian Society of Medical Imaging and Radiation
Therapy acknowledges the diverse Aboriginal and Torres
Strait Islander peoples of Australia as the traditional owners
of the lands upon which we and our members operate.
We pay our respects to their Elders, past, present and
future, and value their continued custodianship of the lands,
waters and seas.
© ASMIRT 2024 | ALL RIGHTS RESERVED | PRIVACY | TERMS | SITEMAP
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram